A Rare Incidence of Ethambutol Induced Toxic Optic Neuropathy
International Journal of Medical and Pharmaceutical Case Reports,
Page 1-5
DOI:
10.9734/ijmpcr/2023/v16i1322
Abstract
Ethambutol induces toxic optic neuropathy (EON), which most typically presents as bilateral symmetrical loss of vision and, due to a lack of early detection and adequate treatment, often causes serious irreversible visual impairment. EON is time and dose dependent. In this case report, we will discuss a 59-year-old female patient who came in with complaints of visual impairment, inclusive of a colour vision defect (dyschromatopsia) and blurred vision (scotoma). Her past medication history includes use of first-line anti-tubercular therapy (ATT) with four drugs: Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide. Pyrazinamide was taken for two months, and other medications (Rifampicin, Isoniazid, and Ethambutol) were taken for a period of seven months. From this case report, we will get a clear picture necessitating continuous monitoring for ocular toxicity.
Keywords:
- Ethambutol-induced Optic Neuropathy (EON)
- Anti-Tubercular Therapy (ATT)
- reversible
- Duration and dose dependent
How to Cite
References
Available:https://pib.gov.in/PressReleasePage.aspx?PRID=1808092
Shamseeda, Jayasree. Epidemiological profile of extrapulmonary tuberculosis and its association with diabetes in tertiary care center in Northern Kerala. Int J Community Med Public Health [Internet]. 2022 [cited 2022 Nov 18];9(6):2590.
Available:https://www.ijcmph.com/index.php/ijcmph/article/view/9762/6005
Song W, Si S. The rare ethambutol-induced optic neuropathy: A case-report and literature review. Medicine (Baltimore) [Internet]. 2017 [cited 2022 Nov 18];96(2):e5889.
Available:http://dx.doi.org/10.1097/md.0000000000005889
Kesler A, Pianka P. Toxic optic neuropathy. Curr Neurol Neurosci Rep [Internet]. 2003 [cited 2022 Nov 18];3(5):410–4.
Available:https://pubmed.ncbi.nlm.nih.gov/12914684/
Sheng W-Y, Wu S-Q, Su L-Y, Zhu L-W. Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: A case report. World J Clin Cases [Internet]. 2022 [cited 2022 Nov 18];10(2):663–70.
Available:http://dx.doi.org/10.12998/wjcc.v10.i2.663
Monika, Kumar J, Rathi M et.al. Ethambutol induced optic neuropathy: a rare case report. International Journal of Research and Review. 2020;7(2):13-17.
Sheng WY, Wu SQ, Su LY, Zhu LW. Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: A case report. World J Clin Cases 2022;10(2):663-670 [PMID: 35097092
DOI: 10.12998/wjcc.v10.i2.663]
Sen S, Mandal S, Banerjee M, Gk R, Saxena A, Aalok SP, et al. Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve. Semin Ophthalmol [Internet]. 2022;37(6):730–9.
Available:http://dx.doi.org/10.1080/08820538.2022.2085517
Shah S, Adhikari YR, Paudel S, Sitaula S, Koirala B, Aryal S, et al. Optic neuropathy induced by ethambutol: A rare case from Nepal. Ann Med Surg (Lond) [Internet]. 2022;77(103637):103637.
Available:https://www.sciencedirect.com/science/article/pii/S2049080122003971
Saxena R, Singh D, Phuljhele S, Kalaiselvan V, Karna S, Gandhi R, et al. Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy. Indian J Ophthalmol [Internet]. 2021 [cited 2023 Jan 13];69(12):3734–9.
Available:http://dx.doi.org/10.4103/ijo.IJO_3746_20
Islam IC, Umar BT, Minhajat R, Bukhari A, Sari DK, Kaelan C. Ethambutol effect on retinal and optic nerve structural changes in toxic optic neuropathy case: A literature review. Ophthalmol Res Int J [Internet]. 2022 [cited 2023 Jan 13];16(3):26–36.
Available:http://eurolibpress.uk/id/eprint/764/
Zhang X-H, Xie Y, Xu Q-G, Cao K, Xu K, Jin Z-B, et al. Mitochondrial mutations in ethambutol-induced optic neuropathy. Front Cell Dev Biol [Internet]. 2021;9:754676.
Available:http://dx.doi.org/10.3389/fcell.2021.754676
-
Abstract View: 61 times
PDF Download: 28 times